New here?
Start Here
TryTrutide is an independent educational platform covering retatrutide — an investigational triple-receptor agonist in Phase 3 clinical trials. Choose the research pathway that matches what you need to know.
TryTrutide is an independent educational platform. Retatrutide is investigational and not FDA approved. Content on this site is not medical advice. Always consult a licensed physician before making any treatment decisions.
Choose your research pathway
I want to understand what retatrutide is
Overview of the drug, its mechanism, drug class, and development history.
What Is Retatrutide? →
I want the current FDA approval status
Current regulatory status, regulatory pathway, compounding status, and date last verified.
Check Current FDA Status →
I want to review clinical trials
TRIUMPH Phase 3 program — NCT IDs, phases, enrollment, and completion dates.
Review Clinical Trials →
I want to understand reported results
Phase 1, 2, and 3 weight-loss and metabolic outcome data with evidence ratings.
Review the Evidence →
I want safety and side-effect information
Adverse event data, severity classifications, contraindications, and emergency guidance.
Understand the Risks →
I want to compare retatrutide with approved medications
Side-by-side comparisons with tirzepatide, semaglutide, and next-generation obesity drugs.
Compare Medications →
I found retatrutide for sale online
Why no online vendor is selling real retatrutide — red flags, cover stories, and legal exposure.
Read the Online Sellers Warning →
I want to find a legitimate clinical trial
How to search ClinicalTrials.gov and enroll in an authorized TRIUMPH trial.
Explore Clinical Trials →